Completed OBSERVATIONAL NCT04517682

COVID-19 and SARS-CoV-2 Detection in Saliva

SARS -CoV-2 Detection in Saliva Samples: A Test Validation Protocol

Sponsor: Ambry Genetics

Interventions RT-PCR

Updated 7 times since 2020 Last updated: Mar 4, 2022 Started: May 21, 2020 Primary completion: Mar 16, 2021 Completion: Aug 5, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates RNA Virus Infections and is currently completed. Ambry Genetics leads this study, which shows 7 recorded versions since 2020 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Apr 2022 — Jul 2024 [monthly]

Completed

Status: Enrolling By Invitation → Completed
Dec 2021 — Apr 2022 [monthly]

Enrolling By Invitation
Jan 2021 — Dec 2021 [monthly]

Enrolling By Invitation

▶ Show 2 earlier versions

Nov 2020 — Jan 2021 [monthly]

Enrolling By Invitation
Sep 2020 — Nov 2020 [monthly]

Enrolling By Invitation

First recorded

May 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ambry Genetics
Crozer-Keystone Health System
St. Joseph Hospital of Orange
The Saratoga Hospital

Data source: Ambry Genetics

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Aliso Viejo, United States